Evidence map›Paper›PMID 26244409›Full record

ArticleACS applied materials & interfaces2015

Protective Polymer Coatings for High-Throughput, High-Purity Cellular Isolation.

Gabriela Romero, Jacob J Lilly, Nathan S Abraham, Hainsworth Y Shin, Vivek Balasubramaniam, Tadahide Izumi, Brad J Berron

Abstract read
In one paragraph

Article in ACS applied materials & interfaces, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Increased yield of gelatin coated therapeutic cells through cholesterol insertion.Journal of biomedical materials research. Part A · 2021
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Hydrogel Patches on Live Cells through Surface-Mediated Polymerization.Langmuir : the ACS journal of surfaces and colloids · 2017
    Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Gabriela Romero
Jacob J Lilly
Nathan S Abraham§Department of Chemical Engineering, University of Massachusetts Amherst, Amherst, Massachusetts 01003, United States.
Hainsworth Y Shin
Vivek Balasubramaniam||Department of Pediatrics, University of Wisconsin, Madison, Wisconsin 53792, United States.
Tadahide Izumi#Graduate Center for Toxicology, University of Kentucky, Lexington, Kentucky 40536, United States.
Brad J Berron
University of Kentucky · USUniversity of Massachusetts Amherst · USUniversity of Wisconsin–Madison · US

Funding

Specific Lysis for Large-Volume, High-Purity Endothelial Progenitor Cell IsolatesR01HL127682 · NHLBI · UNIVERSITY OF KENTUCKY · PI BERRON, BRADLEY JOSEPH · 2015 to 2018
$2.3M
The University of Kentucky Cancer Nanotechnology Training Center (UK CNTC)R25CA153954 · NCI · UNIVERSITY OF KENTUCKY · PI ANDERSON, BRADLEY D, EVERS, BERNARD MARK · 2010 to 2014
$1.6M
Collaboration in the Development of Novel Polymerization Enhanced ImmunofluoresceR21EB012188 · NIBIB · UNIVERSITY OF COLORADO · PI BOWMAN, CHRISTOPHER N · 2011 to 2012
$413k
NCI NIH HHS R25 CA153954NCI NIH HHS R25CA153954NHLBI NIH HHS R01 HL127682NHLBI NIH HHS R01 HL127682−01NIBIB NIH HHS R21 EB012188
6 · The paper itself

Abstract

Cell-based therapies are emerging as the next frontier of medicine, offering a plausible path forward in the treatment of many devastating diseases. Critically, current methods for antigen positive cell sorting lack a high throughput method for delivering ultrahigh purity populations, prohibiting the application of some cell-based therapies to widespread diseases. Here we show the first use of targeted, protective polymer coatings on cells for the high speed enrichment of cells. Individual, antigen-positive cells are coated with a biocompatible hydrogel which protects the cells from a surfactant solution, while uncoated cells are immediately lysed. After lysis, the polymer coating is removed through orthogonal photochemistry, and the isolate has >50% yield of viable cells and these cells proliferate at rates comparable to control cells. Minority cell populations are enriched from erythrocyte-depleted blood to >99% purity, whereas the entire batch process requires 1 h and <$2000 in equipment. Batch scale-up is only contingent on irradiation area for the coating photopolymerization, as surfactant-based lysis can be easily achieved on any scale.

Indexed as

Antibodies, ImmobilizedAntigens, NeoplasmBiocompatible MaterialsCell Adhesion MoleculesCell Line, TumorCell ProliferationCell SeparationCell SurvivalEpithelial Cell Adhesion MoleculeHumansHydrogelsJurkat CellsLeukocyte Common AntigensNanoparticlesPolymersSurface-Active AgentsAntibodies, ImmobilizedAntigens, NeoplasmBiocompatible MaterialsCell Adhesion MoleculesEpithelial Cell Adhesion MoleculeHydrogelsLeukocyte Common AntigensPolymersSurface-Active Agentscell isolationcoatingsphotopolymerizationpolymerprotein expressionsorting

Identifiers

PMID26244409
PMCPMC4544319
OpenAlexW2436817407

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.